CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Sk Biopharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 27, 2024Use Of Carbamate Compound For Preventing, Alleviating Or Treating Absence Seizure Or Epilepsy Showing Absence Seizure2
Dec 20, 2023Solvate Form Of (R)-2-Amino-3-Phenylpropyl Carbamate1
Jul 20, 2022Treatment Of Cataplexy1

Top competitors of Sk Biopharmaceuticals

List of top competitors of Sk Biopharmaceuticals based on patent oppositions.